Yuting Li

Beijing, 100853, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Integrated single-cell and functional analyses define strategies to enhance dendritic cell immunostimulatory capacity.

Integrated single-cell and functional analyses define strategies to enhance dendritic cell immunostimulatory capacity.

Journal: Discover oncology

Published: January 23, 2026

Association Between Hepatic Steatosis With Significant Fibrosis and CAD Severity in Different Glucose Metabolic States: A CSCD-TCM plus Study.

Association Between Hepatic Steatosis With Significant Fibrosis and CAD Severity in Different Glucose Metabolic States: A CSCD-TCM plus Study.

Journal: Angiology

Published: November 12, 2025

Current progress in neoantigen-based dendritic cell vaccines for solid tumors.

Current progress in neoantigen-based dendritic cell vaccines for solid tumors.

Journal: Cancer biology & medicine

Published: September 30, 2025

Investigating Liquid-Liquid Phase Separation in Lung Adenocarcinoma to Improve Prognostic Accuracy and Treatment Efficacy.

Investigating Liquid-Liquid Phase Separation in Lung Adenocarcinoma to Improve Prognostic Accuracy and Treatment Efficacy.

Journal: Journal of cellular and molecular medicine

Published: February 05, 2025

Release of damaged mitochondrial DNA: A novel factor in stimulating inflammatory response.

Release of damaged mitochondrial DNA: A novel factor in stimulating inflammatory response.

Journal: Pathology, research and practice

Published: December 28, 2023

A disulfidptosis-related lncRNA signature for predicting prognosis and evaluating the tumor immune microenvironment of lung adenocarcinoma.

A disulfidptosis-related lncRNA signature for predicting prognosis and evaluating the tumor immune microenvironment of lung adenocarcinoma.

Journal: Scientific reports

Published: October 05, 2023

Autophagy and Glycometabolic Reprograming in the Malignant Progression of Lung Cancer: A Review.

Autophagy and Glycometabolic Reprograming in the Malignant Progression of Lung Cancer: A Review.

Journal: Technology in cancer research & treatment

Published: August 22, 2023

A mutational signature and significantly mutated driver genes associated with immune checkpoint inhibitor response across multiple cancers.

A mutational signature and significantly mutated driver genes associated with immune checkpoint inhibitor response across multiple cancers.

Journal: International immunopharmacology

Published: November 18, 2022

HSPG2 Mutation Association with Immune Checkpoint Inhibitor Outcome in Melanoma and Non-Small Cell Lung Cancer.

HSPG2 Mutation Association with Immune Checkpoint Inhibitor Outcome in Melanoma and Non-Small Cell Lung Cancer.

Journal: Cancers

Published: June 06, 2022

Evodiamine suppresses the progression of non-small cell lung carcinoma via endoplasmic reticulum stress-mediated apoptosis pathway in vivo and in vitro.

Evodiamine suppresses the progression of non-small cell lung carcinoma via endoplasmic reticulum stress-mediated apoptosis pathway in vivo and in vitro.

Journal: International journal of immunopathology and pharmacology

Published: April 07, 2022

An aging-related signature predicts favorable outcome and immunogenicity in lung adenocarcinoma.

An aging-related signature predicts favorable outcome and immunogenicity in lung adenocarcinoma.

Journal: Cancer science

Published: November 23, 2021

Somatic mutations in DCC are associated with genomic instability and favourable outcomes in melanoma patients treated with immune checkpoint inhibitors.

Somatic mutations in DCC are associated with genomic instability and favourable outcomes in melanoma patients treated with immune checkpoint inhibitors.

Journal: British journal of cancer

Published: November 17, 2021

Showing 1-12 of 22

Last Updated: 09/26/2026